Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes

Journal of Infectious Diseases

Volumn 196, Issue 6, 2007, Pages 826-834

  Janssen, Riny ^a   Bont, Louis ^b   Siezen, Christine L E ^a   Hodemaekers, Hennie M ^a   Ermers, Marieke J ^b   Doornbos, Gerda ^a   Van 'T Slot, Ruben ^c   Wijmenga, Ciska ^c   Goeman, Jelle J ^d   Kimpen, Jan L L ^b   Van Houwelingen, Hans C ^a,d   Kimman, Tjeerd G ^a   Hoebee, Barbara ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ARTICLE; CHEMOTAXIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HUMAN CELL; INFANT; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT MUCOSA; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL BRONCHIOLITIS;

ASTHMA; BRONCHIOLITIS, VIRAL; CHEMOTAXIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNITY; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 34548475750     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520886     Document Type: Article

References (41)

1. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003; 22:S40-4.
2. Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 2003; 22:S13-8.
3. Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002; 186:1207-11.
4. Hoebee B, Rietveld E, Bont L, et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor α polymorphisms. J Infect Dis 2003; 187:2-11.
5. Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 2006; 193:438-41.
6. Tal G, Mandelberg A, Dalal I, et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189:2057-63.
7. Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002; 51:696-9.
8. Hoebee B, Bont L, Rietveld E, et al. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-α genes on respiratory syncytial virus bronchiolitis. J Infect Dis 2004; 189:239-47.
9. Kimman TG, Janssen R, Hoebee B. Future prospects in respiratory syncytial virus genetics. Future Virology 2006; 1:483-92.
10. Hall CB, Douglas RG Jr, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis 1975; 132:151-6.
11. Buckingham SC, Bush AJ, Devincenzo JP. Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants. Pediatr Infect Dis J 2000; 19:113-7.
12. Wright PF, Gruber WC, Peters M, et al. Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002; 185:1011-8.
13. Wheeler JG, Wofford J, Turner RB. Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection. Pediatr Infect Dis J 1993; 12:209-13.
14. Meert KL, Sarnaik AP, Gelmini MJ, Lieh-Lai MW. Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit Care Med 1994; 22:566-72.
15. Guerguerian AM, Gauthier M, Lebel MH, Farrell CA, Lacroix J. Ribavirin in ventilated respiratory syncytial virus bronchiolitis: a randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999; 160:829-34.
16. Janssen R, Pennings J, Hodemaekers HM, et al. Host transcription profiles upon primary respiratory syncytial virus infection. J Virol 2007;81:5958-67.
17. Viet AL, van Gils HWV, de Melker H, et al. Risk factors and health in The Netherlands, a survey by municipal health centers; annual report 1998. Centraal Bureau voor de Statistiek (CBS-KPE). GGD Nederland RIBM Rapport 266807003. Available at: http://www.rivm.nl/bibliotheek/rapporten/266807003.html. Accessed 6 August 2007.
18. Cordell HJ, Barratt BJ, Clayton DG. Case/pseudocontrol analysis in genetic association studies: a unified framework for detection of genotype and haplotype associations, gene-gene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol 2004; 26: 167-85.
19. Nagelkerke NJ, Hoebee B, Teunis P, Kimman TG. Combining the transmission disequilibrium test and case-control methodology using generalized logistic regression. Eur J Hum Genet 2004; 12:964-7.
20. Epstein MP, Waldman ID, Satten GA. Improved association analyses of disease subtypes in case-parent triads. Genet Epidemiol 2006; 30: 209-19.
21. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004; 20:93-9.
22. Taverna MJ, Selam JL, Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab 2005; 90:4803-8.
23. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000; 355:618-21.
24. Poon AH, Laprise C, Lemire M, et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med 2004; 170:967-73.
25. Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995; 53:599-602.
26. Levecque C, Elbaz A, Clavel J, et al. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet 2003; 12:79-86.
27. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84:731-65.
28. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006; 344:328-39.
29. Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004; 30:893-90.
30. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001; 79: 376-84.
31. Hasegawa M, Nishiyama C, Nishiyama M, et al. A novel -66T/C polymorphism in FcεRI α-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J Immunol 2003; 171: 1927-33.
32. Kurz T, Strauch K, Dietrich H, et al. Multilocus haplotype analyses reveal association between 5 novel IL-15 polymorphisms and asthma. J Allergy Clin Immunol 2004; 113:896-901.
33. Hellier S, Frodsham AJ, Hennig BJ, et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003; 38:1468-76.
34. Zee RY, Bates D, Ridker PM. A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke. Stroke 2002; 33: 892-5.
35. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24:677-88.
36. Hackstein H, Hecker M, Kruse S, et al. A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor α-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 2001; 53:264-90.
37. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51:605-12.
38. Noguchi E, Yokouchi Y, Shibasaki M, et al. Association between TNFA polymorphism and the development of asthma in the Japanese population. Am J Respir Crit Care Med 2002; 166:43-6.
39. van Heel DA, Udalova IA, De Silva AP, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum Mol Genet 2002; 11:1281-90.
40. Vafiadis P, Bennett ST, Todd JA, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15:289-92.
41. Doherty PC, Zinkernagel RM. Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975; 256:50-2.